A Long-Term, Open-Label Safety and Maintenance of Efficacy Study of JZP-110[(R)-2-amino3-phenylpropylcarbamate hydrochloride] in the Treatment of Excessive Sleepiness in subjects with Narcolepsy or Obstructive Sleep Apnea
Clinical Trial Grant
Administered By
Neurology, Epilepsy and Sleep
Awarded By
Jazz Pharmaceuticals
Start Date
September 1, 2015
End Date
April 18, 2018
Administered By
Neurology, Epilepsy and Sleep
Awarded By
Jazz Pharmaceuticals
Start Date
September 1, 2015
End Date
April 18, 2018